Luke Rosen is the co-founder of KIF1A.ORG, a research and advocacy organization working to develop treatment for KIF1A Associated Neurological Disorder (KAND). Additionally, Luke serves as vice president of Patient Engagement & Government Affairs at Ovid Therapeutics.

X